Pennies from Heaven

[LoMo]

(Long) ILMN - Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Illumina has been a top growth for many years now and has averaged more than 30% earnings growth over the past five years. And is expected to grow earnings at more than 25% per year over the next five years. Although they beat earnings expectations three of the past four quarters according to Yahoo Finance, estimates fell slightly over the past couple months. Gross margin is nearly 67% and return on equity is 11.67%. The price took a dive starting in late July but it has now started a rounding bottom pattern. Our target entry is tomorrow morning with a target sell price of $62.10. Our stop-loss $45.40.


alert 9-14-11